Roles of the TGF-β⁻VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
chronic kidney disease 3 nephrologydiseases
glomerulonephritis 1 nephrologydiseases
nephrosclerosis 1 nephrologydiseases

There are not enough annotations found in this document to create the proximity graph.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Select Disease Character Offset Disease Term Instance
chronic kidney disease 923 during the progression of tissue fibrosis in various clinical and pathological situations, such as chronic kidney disease , peritoneal injury during peritoneal dialysis, tissue inflammation, and tumor progression. The role
chronic kidney disease 15017 production in macrophages [[65]]. Interestingly, in the rat remnant kidney model, it was demonstrated that chronic kidney disease itself induced peritoneal fibrosis, lymphangiogenesis, and a high lymphatic absorption rate, independent
chronic kidney disease 31303 neoangiogenesis, and inflammation [[116],[117]]. CTGF strongly contributes to the development and progression of chronic kidney disease (CKD) [[118]]. CTGF is overexpressed in various kidney diseases such as diabetic nephropathy [[119]],
glomerulonephritis 31477 kidney diseases such as diabetic nephropathy [[119]], hypertensive nephrosclerosis [[120]], crescentic glomerulonephritis [[121]], and renal allograft fibrosis [[122]]. CTGF expression correlates with the severity of renal
nephrosclerosis 31441 CTGF is overexpressed in various kidney diseases such as diabetic nephropathy [[119]], hypertensive nephrosclerosis [[120]], crescentic glomerulonephritis [[121]], and renal allograft fibrosis [[122]]. CTGF expression

You must be authorized to submit a review.